CymaBay Therapeutics, Inc. — Form D

CymaBay Therapeutics, Inc. of NEWARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-10. The offering totals $8.6M, of which $5.6M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Bradley BolzonDirectorSAN DIEGO, CA
Anthony EvninDirectorCambridge, MA
Carl GoldfischerDirectorSan Diego, CA
Louis LangeDirectorPalo Alto, CA
Edward PenhoetDirectorSeattle, WA
Daan van den NoortDirectorHaarlem, P7
Harold Van WartDirectorHayward, CA
Kurt von EmsterDirectorRedwood City, CA
Robert ZerbeDirectorGrand Rapids, MI
Donald HillExecutive OfficerCoral Gables, FL
David KarpfExecutive OfficerHayward, CA
Charles McWherterExecutive OfficerHayward, CA
Paul QuinlanExecutive OfficerNew York, NY
Harold Van WartExecutive OfficerHayward, CA
Harold Van Wart, Ph. D.DirectorNewark, CA
Harold Van Wart, Ph. D.Executive OfficerNewark, CA
Carl G Goldfischer, M.D.DirectorNewark, CA
Pol J BoudesExecutive OfficerNewark, CA
Kurt G von EmsterDirectorNewark, CA
Hari G Kumar, Ph.D.DirectorNewark, CA
Charles A McWherter, Ph. D.Executive OfficerNewark, CA
Louis G Lange, M.D., Ph.D.DirectorNewark, CA
Robert J WillsDirectorNewark, CA
Sujal A ShahExecutive OfficerNewark, CA
Edward E Penhoet, Ph.D.DirectorHayward, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2015-08-14D$325K$325K
2013-11-01D/A$45.0M$30.2M
2013-10-11D$45.0M$26.8M
2009-07-21D/A$27.7M$27.7M

More